AKSHAYA BIO

akshaya-bio-logo

Akshaya develops innovative therapeutics for infectious diseases and cancer. Akshaya's proprietary Chimigenยฎ Platform Technology uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet medical needs such as treatments for chronic hepatitis B and hepatitis C virus infections, avian and swine influenza, alphavirus infections, malaria, HIV and cancer.

#SimilarOrganizations #People #Website #More

AKSHAYA BIO

Industry:
Biotechnology Medical Pharmaceutical

Address:
Edmonton, Alberta, Canada

Country:
Canada

Website Url:
http://www.akshayabio.com

Status:
Active

Contact:
(780) 433-4411

Email Addresses:
[email protected]

Technology used in webpage:
SPF Apple Mobile Web Clips Icon IPv6 Apache Microsoft Azure DNS Common Name Invalid GoDaddy DNS Microsoft GlobalSign Nexcess


Similar Organizations

not_available_image

Advanced Microscopy Group

Advanced Microscopy Group is a privately held developer of imaging systems for research microscopy.

therapyx-logo

Therapyx

TherapyX is a privately held development-stage biotechnology company.

x-rx-inc-logo

X-Rx Inc.

X-Rx Inc. is a privately held biotechnology company

Current Employees Featured

rajan-george_image

Rajan George
Rajan George Founder, President & Chief Scientific Officer @ Akshaya Bio
Founder, President & Chief Scientific Officer
2012-01-01

Official Site Inspections

http://www.akshayabio.com

  • Host name: phantom.nexcess.net
  • IP address: 69.160.59.34
  • Location: Southfield United States
  • Latitude: 42.4593
  • Longitude: -83.2207
  • Metro Code: 505
  • Timezone: America/Detroit
  • Postal: 48075

Loading ...

More informations about "Akshaya Bio"

Akshaya Bio - Crunchbase Company Profile & Funding

Organization. Akshaya Bio . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Legal Name Akshaya Bio โ€ฆSee details»

Akshaya Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Akshaya Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature, Disease Domain:Infectious Diseases, Technology ...See details»

Akshaya Bio Company Profile | Management and Employees List

Akshaya Bio Profile and History Akshaya Bio, Inc., a Canadian development stage biotechnology company ("Akshaya"), and its wholly owned subsidiary Chimigen Inc., a US-based company โ€ฆSee details»

Akshaya Bio Inc. - Develops Innovative Therapeutics For Infectious ...

Akshaya Bio Inc. (Akshaya) is a privately held development stage biotechnology company located in Edmonton, Alberta, Canada. Akshaya develops innovative therapeutics for infectious โ€ฆSee details»

Akshaya Bio - Company Profile - Tracxn

Nov 27, 2024 Akshaya Bio is a Canadian, private, development-stage biotech developing chimeric antibody therapeutics for infectious diseases and cancer. It has a proprietary โ€ฆSee details»

Akshaya Bio - Craft

Akshaya Bio is a biotechnology company that develops therapeutics for infectious diseases and cancer. It uses Chimigen platform technology that implements dendritic cell receptor-targeted โ€ฆSee details»

Akshaya Bio Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Akshaya Bio Inc of Edmonton, AB. Get the latest business insights from Dun & Bradstreet.See details»

Akshaya Bio - Overview, News & Similar companies - ZoomInfo

OKLAHOMA CITY, April 23, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the โ€ฆSee details»

Akshaya Bio | Company Profile | Pharmacompass.com

Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary โ€ฆSee details»

Akshaya Bio Inc Information - RocketReach

The NAICS codes for Akshaya Bio Inc are [32, 32541, 3254, 325414, 325]. What is the SIC code for Akshaya Bio Inc? The SIC codes for Akshaya Bio Inc are [283, 28]. Related Companies No โ€ฆSee details»

Akshaya Bio Inc - National Company | Open Datasets

Company Name: Akshaya Bio Inc Category: Biotechnology Research Services Industry City: Edmonton,Ab,T6E6S4 Country: Canada Telephone: *****9993 Profile: Akshaya Bio Inc is โ€ฆSee details»

Akshaya Bio, Inc.:Company Profile & Technical โ€ฆ

Akshaya Bio, Inc. has a total of 41 patents Related Topics Medicine Infection drug Drug development Drug discovery Alphavirus infection Biotherapeutic agent Hepatitis C virus โ€ฆSee details»

Akshaya Bio - Products, Competitors, Financials, Employees ...

Akshaya Bio is a privately held development stage biotechnology company. Akshaya develops therapeutics for infectious diseases and cancer. Akshaya's proprietary Chimigen Platform โ€ฆSee details»

Akshaya BIO - VentureRadar

Flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in hosts. ... Find out more about Akshaya BIO, Vaccines.See details»

Akshaya Bio - Contacts, Employees, Board Members, Advisors

Organization. Akshaya Bio . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Akshaya Bio has 1 current โ€ฆSee details»

Akshaya Bio DMF, CEP, Written Confirmations, FDF, Prices, Patents ...

Akshaya Bio Inc. (Akshaya) is a privately held development stage biotechnology company located in Edmonton, Alberta, Canada. Akshaya develops innovative therapeutics for infectious โ€ฆSee details»

Akshaya Bio, Inc.: Chimigen® Technology - Leaders in โ€ฆ

Akshaya Bio, Inc.: Chimigen® Technology - Rajan George, PhD, President and CSO Re-educating Immune System to Fight Diseases www.akshayabio.com Unique technology โ€ฆSee details»

Akshaya Bio - Edmonton - Infobel

In Edmonton, Infobel has listed 91,909 registered companies. These companies have an estimated turnover of $ 282.193 billions and employ a number of employees estimated at โ€ฆSee details»

Chimigen HBV Vaccine(Akshaya) - Drug Targets, Indications

Chimigen HBV Vaccine(Akshaya): a Immunostimulants Drug, Initially developed by Akshaya Bio, Inc., Now, its global highest R&D status is Preclinical, Mechanism ...See details»

Research programme: vaccines - Akshaya Bio - AdisInsight - Springer

If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโ€™s network Login with username/password or try to โ€ฆSee details»

linkstock.net © 2022. All rights reserved